Escalating dosing regimen for effecting weight loss and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7048 (2006.01) A61P 3/04 (2006.01) A61K 47/38 (2006.01)

Patent

CA 2727313

The present invention is drawn to novel topiramate compositions as well as methods for effecting weight loss, e.g., in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se. The present invention features an escalating dosing regimen adapted for the administration of topiramate and optionally a sympathomimetic agent such as phentermine or bupropion, in the treatment of obesity and related conditions.

La présente invention concerne de nouvelles compositions de topiramate ainsi que des procédés visant à obtenir une perte de poids, par exemple, dans le traitement de lobésité et daffections apparentées, y compris des affections associées à et/ou causées par lobésité en soi. Linvention a pour objet un protocole dadministration de doses croissantes adapté à ladministration de topiramate et éventuellement dun agent sympathomimétique tel que la phentermine ou le bupropion, dans le traitement de lobésité et daffections apparentées.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Escalating dosing regimen for effecting weight loss and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Escalating dosing regimen for effecting weight loss and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Escalating dosing regimen for effecting weight loss and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1936664

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.